Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Jerome D Jabbour Net Worth & Insider Trades

Jerome D Jabbour - President and CEO, Matinas Biopharma Holdings, Inc

As of December 22, 2022

What is Jerome D Jabbour's Net Worth?

The current estimated net worth of Matinas Biopharma Holdings, Inc's President and CEO, Jerome D Jabbour, is estimated to be about $382.83K . Jerome D Jabbour owns about 799,511 units of Matinas Biopharma Holdings, Inc common stock. In the last 4 years at Matinas Biopharma Holdings, Inc, Jerome D Jabbour has sold an estimated value of $0 worth.

What is Jerome D Jabbour's Past Insider Trading?

Jerome D Jabbour's largest purchase order was 12,487 units , worth over $9.98K on June 13, 2019. In total, Jerome D Jabbour has made about 12 transactions over 4 years of their time at Matinas Biopharma Holdings, Inc. Jerome D Jabbour usually trades in June, with the busiest year in 2020. The most recent transaction was a purchase order of 10,000 units , worth over $6.5K on March 18, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jerome D Jabbour

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jerome D Jabbour's' Mailing Address?

  • Mailing address is C/o Matinas Biopharma Holdings, Inc. 1545 Route 206, Suite 302 Bedminster NJ 07921 NJ

What are Matinas Biopharma Holdings, Inc's Past Insider Trades?

Matinas Biopharma Holdings, Inc's most recent insider trade came on August 24, 2020 by Adam K Stern who bought 20,000 units worth $16.6K . In the last 3 years, insiders at Matinas Biopharma Holdings, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in November, with the busiest year in 2019. The most active traders at the company are Matthew Wikler, Director,  Herbert J Conrad, Director,  and James S Scibetta, Director .

Matinas BioPharma Holdings, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...